Pulmonary Hypertension News and Research

RSS
Pulmonary arterial hypertension (PAH) is a condition involving high blood pressure and structural changes in the walls of the pulmonary arteries, which are the blood vessels that connect the right side of the heart to the lungs. Affecting people of all ages and ethnic backgrounds - but most commonly found in young women of child-bearing years - the disease has historically been chronic and incurable, with a poor survival rate. PAH is often not diagnosed in a timely manner because its early symptoms can be confused with those of many other pulmonary and respiratory conditions. Symptoms include shortness of breath, extreme fatigue, dizziness, fainting, swollen ankles and legs and chest pain (especially during physical activity). With proper diagnosis, there are currently several therapies to alleviate symptoms and improve quality of life for PAH patients. The key is to find a PAH specialist and pursue immediate treatment.
Special publication details breakthrough research on causes of vascular disease

Special publication details breakthrough research on causes of vascular disease

Women In Government announces launch of Pulmonary Hypertension Legislative Toolkit

Women In Government announces launch of Pulmonary Hypertension Legislative Toolkit

Ikaria shareholders to sell Commercial Business to Madison Dearborn Partners

Ikaria shareholders to sell Commercial Business to Madison Dearborn Partners

Researchers discover direct evidence of genetic overlap between cognitive ability and schizophrenia

Researchers discover direct evidence of genetic overlap between cognitive ability and schizophrenia

Detectable blood viral load increases prevalence of heart disease

Detectable blood viral load increases prevalence of heart disease

Researchers discover new genetic risk factor for schizophrenia, bipolar disorder

Researchers discover new genetic risk factor for schizophrenia, bipolar disorder

New research devises effective way to evaluate severity of pulmonary hypertension

New research devises effective way to evaluate severity of pulmonary hypertension

New biosensor could help doctors devise new ways to minimize brain damage during heart surgery

New biosensor could help doctors devise new ways to minimize brain damage during heart surgery

Multidisciplinary team tests innovative heart failure therapy in global clinical trials

Multidisciplinary team tests innovative heart failure therapy in global clinical trials

ATS and ACCP release five recommendations for tests, procedures in pulmonary medicine

ATS and ACCP release five recommendations for tests, procedures in pulmonary medicine

New pulmonary medicine list includes five recommendations to improve patient care and outcomes

New pulmonary medicine list includes five recommendations to improve patient care and outcomes

Adempas drug gets FDA approval for treatment of pulmonary hypertension

Adempas drug gets FDA approval for treatment of pulmonary hypertension

Bayer HealthCare receives FDA approval for Adempas tablets

Bayer HealthCare receives FDA approval for Adempas tablets

Researchers identify protein that triggers inflammation in patients with hemorrhage, sepsis

Researchers identify protein that triggers inflammation in patients with hemorrhage, sepsis

NCI explores how erectile dysfunction drugs work to prevent colon cancer

NCI explores how erectile dysfunction drugs work to prevent colon cancer

PGI2 analogs, PDE5 inhibitors stimulate enhanced release of vasodilator ATP from human RBCs

PGI2 analogs, PDE5 inhibitors stimulate enhanced release of vasodilator ATP from human RBCs

Researchers develop synthetic peptide that could be a new class of drugs for heart disease

Researchers develop synthetic peptide that could be a new class of drugs for heart disease

Pulmonary hypertension may be caused by molecular pathway that damages blood vessels

Pulmonary hypertension may be caused by molecular pathway that damages blood vessels

ATS releases clinical practice guidelines on management of childhood ILD in infants

ATS releases clinical practice guidelines on management of childhood ILD in infants

Miniscule signaling molecule plays critical role in certain acute and chronic diseases

Miniscule signaling molecule plays critical role in certain acute and chronic diseases

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.